Baxter International Inc.

Stock Symbol: BAX

Baxter International Inc. Description:
Baxter International Inc. is a global medical products and services company that, through its subsidiaries, provides critical therapies for people with life-threatening conditions. Baxter's products and services in bioscience (biopharmaceuticals, vaccines, biosurgery and transfusion therapies), medication delivery and renal therapy are used by health-care providers and their patients in more than 100 countries.

Baxter International Inc. Financial Summary:
For the 9 months ended 30 September 2005, Baxter International Inc's revenues rose 7% to $7.36B. Net income from continuing operations totaled $664M, up from $277M. Revenues reflect higher sales growth in recombinant business and bioscience business. Net income also reflects increased gross profit margins, lower special charges and higher interest income. The Company provides its expertise in medical devices, pharmaceuticals & biotechnology.

Baxter International Inc. Business Summary:
Baxter International Inc. operates as a global medical products and services company specializing in medical devices, pharmaceuticals and biotechnology to assist healthcare professionals and their patients with the treatment of medical conditions, including hemophilia, immune disorders, infectious diseases, cancer, kidney disease, trauma and other conditions. The Company operates in three segments: Medication delivery, which provides a range of intravenous (IV) solutions and specialty products that are used in combination for fluid replenishment, general anesthesia, nutrition therapy, pain management, antibiotic therapy and chemotherapy; BioScience, which develops biopharmaceuticals, biosurgery products, vaccines and blood collection, processing and storage products and technologies for transfusion therapies, and Renal, which develops products and provides services to treat end-stage kidney disease. Baxter manufactures products in 28 countries and sells them in over 100 countries.